slideshare analytics ajaz hussain 1 march 2014
DESCRIPTION
Thanking viewers of my presentation slides on topics such as Biopharmaceutics Classification System, BCS, FDA, PAT, QbD, Biosimilars, Product Development, Process Development, Data Integrity, Human Factors, and GMPs, biowaivers, warning lettersTRANSCRIPT
Viewers of my uploads on Slideshare®
Top 10 %United States 36.2
India 16.1
Portugal 6.5
United Kingdom 3.6
Ukraine 3.1
Canada 2.4
Switzerland 2.0
Japan 1.7
Germany 1.7
France 1.6
Viewers from 122 Countries
23/1/2014 [email protected]
Top content (21-27 February 2014)
Name Views
Data in÷teg÷ri÷ty: Time to Integrate Human Factors 90
Human factors in GMP (7 February 2014) 61
Biopharmaceutics Classification System (BCS) & Waiver of Bioequivalence
51
Nanotechnology Regualtory Perspectives, Challenges & Issues 13 February 2014 Post
47
US FDA's PAT Guidance – 10 years and now 17
33/1/2014 [email protected]
Top content: Past six months
Name Views
Biopharmaceutics Classification System (BCS) & Waiver of Bioequivalence
1,540
Data in÷teg÷ri÷ty: Time to Integrate Human Factors 588
Human factors in GMP (7 February 2014) 492
Pharmaceutical Product & Process Design & Quality 332
Pharmaceutical Quality by Design: Review of Progress and Challenges
187
43/1/2014 [email protected]
Top content: Past one year
Name Views
Biopharmaceutics Classification System (BCS) & Waiver of Bioequivalence
6,337
Development of Biosimilar Products: Determinants of Success 993
Chemometrics, Pharmacometrics and Econometrics Dimensions_of_Quality
654
Regulatory Challenges: Lecture @ University of Michigan 21 Feb 2013
591
Data in÷teg÷ri÷ty: Time to Integrate Human Factors 588
53/1/2014 [email protected]
Actions
• FACEBOOK: 6• TWITTER: 9• FAVORITES: 14• EMAILS: 218• LINKEDIN: 374• TOTAL VIEWS: 16,517
3/1/2014 [email protected] 6